Posts Tagged ‘Medicare’

Additional information on the Medicare Prescription Drug Benefit Copayment and premium amounts for 2017: Part B premium: $109 per month on average. If your income is above $85,000 (single) or $170,000 (married couple), then your Medicare Part B premium may be higher. Co-payments: Inpatient hospital deductible: $1,316. Inpatient hospital copay for days 61 – 90: […]

Elder Law & Legal Resources on the Web

March 31st, 2017 by David Goldfarb

Elder Law Related Legal Resources on the Web Access America for Seniors: a government-wide initiative to deliver electronic services from government agencies and organizations to seniors (sponsored by the National Partnership for Reinventing Government and the Government Information Technology Services). National Senior Citizens Law Center: Current issues in Medicaid, Medicare, SSI, benefits and eligibility. Resources […]

New York State Medicaid Law

January 9th, 2017 by David Goldfarb

New York Medicaid Attorneys Don’t make a mistake with Medicaid eligibility; contact a New York elder law attorney with knowledge of Medicaid law.  Goldfarb Abrandt Salzman & Kutzin LLP is a law firm that handles New York Medicaid cases. Updated with 2017 income, resource and penalty rates Introduction Medicaid is a joint federal, state and […]

Information for Attorneys

October 11th, 2013 by David Goldfarb

This section of SeniorLaw provides information for attorneys. The Resource Page, “Elder Law & Legal Resources on the Web,” links to resources on Elder Law, Elder Care, Government Agencies, Searchable Statutes and Court Decisions, and lots more. In “Medicaid & Medicare” we will try to answer questions like “Is there a fraudulent conveyance theory for […]

Including information on the Health Care Reform Provisions of 2010 Affecting the Medicare Prescription Drug Donut Hole With great fanfare, on December 8, 2003, President Bush signed into law the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the “Act”). The Act provides for the establishment of a voluntary drug benefit under a new […]